Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 2 Device Recall SCORPIO CR TIBIAL TRIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
  Class 2 Device Recall SCORPIO CR TIBIAL TRIAL see related information
Date Initiated by Firm July 13, 2010
Date Posted March 16, 2011
Recall Status1 Terminated 3 on September 29, 2017
Recall Number Z-1681-2011
Recall Event ID 56332
Product Classification Prosthesis, knee, patellofemorotibial, semi-constrained, cemented, polymer/metal/polymer - Product Code JWH
Product SCORPIO CR TIBIAL TRIAL, non sterile, made in the USA
Howmedica Osteonics Corp., 325 Corporate Drive, Mahwah, NJ 07430.

The Tibial trial are utilized during surgery to assess the overall component fit, ligament stability, and joint range of motion prior to final implantation of the insert to the tray.
Code Information T72-2-0308 SCORPIO CR TIBIAL TRIAL, SIZE 3, 8 MM T72-2-0310 SCORPIO CR TIBIAL TRIAL, SIZE 3, 10 MM T72-2-0312 SCORPIO CR TIBIAL TRIAL, SIZE 3, 12 MM T72-2-0315 SCORPIO CR TIBIAL TRIAL, SIZE 3, 15 MM T72-2-0318 SCORPIO CR TIBIAL TRIAL, SIZE 3, 18 MM T72-2-0321 SCORPIO CR TIBIAL TRIAL, SIZE 3, 21 MM T72-2-0324 SCORPIO CR TIBIAL TRIAL, SIZE 3, 24 MM T72-2-0508 SCORPIO CR TIBIAL TRIAL, SIZE 5, 8 MM T72-2-0510 SCORPIO CR TIBIAL TRIAL, SIZE 5, 10 MM T72-2-0512 SCORPIO CR TIBIAL TRIAL, SIZE 5, 12 MM T72-2-0515 SCORPIO CR TIBIAL TRIAL, SIZE 5, 15 MM T72-2-0518 SCORPIO CR TIBIAL TRIAL, SIZE 5, 18 MM T72-2-0521 SCORPIO CR TIBIAL TRIAL, SIZE 5, 21 MM T72-2-0524 SCORPIO CR TIBIAL TRIAL, SIZE 5, 24 MM T72-2-0708 SCORPIO CR TIBIAL TRIAL, SIZE 7, 8 MM T72-2-0710 SCORPIO CR TIBIAL TRIAL, SIZE 7, 10 MM T72-2-0712 SCORPIO CR TIBIAL TRIAL, SIZE 7, 12 MM T72-2-0715 SCORPIO CR TIBIAL TRIAL, SIZE 7, 15 MM T72-2-0718 SCORPIO CR TIBIAL TRIAL, SIZE 7, 18 MM T72-2-0721 SCORPIO CR TIBIAL TRIAL, SIZE 7, 21 MM T72-2-0724 SCORPIO CR TIBIAL TRIAL, SIZE 7, 24 MM T72-2-0908 SCORPIO CR TIBIAL TRIAL, SIZE 9, 8 MM T72-2-0910 SCORPIO CR TIBIAL TRIAL, SIZE 9, 10 MM T72-2-0912 SCORPIO CR TIBIAL TRIAL, SIZE 9, 12 MM T72-2-0915 SCORPIO CR TIBIAL TRIAL, SIZE 9, 15 MM T72-2-0918 SCORPIO CR TIBIAL TRIAL, SIZE 9, 18 MM T72-2-0921 SCORPIO CR TIBIAL TRIAL, SIZE 9, 21 MM T72-2-0924 SCORPIO CR TIBIAL TRIAL, SIZE 9, 24 MM T72-2-1108 SCORPIO CR TIBIAL TRIAL, SIZE 11, 8 MM T72-2-1110 SCORPIO CR TIBIAL TRIAL, SIZE 11, 10 MM T72-2-1112 SCORPIO CR TIBIAL TRIAL, SIZE 11, 12 MM T72-2-1115 SCORPIO CR TIBIAL TRIAL, SIZE 11, 15 MM T72-2-1118 SCORPIO CR TIBIAL TRIAL, SIZE 11, 18 MM T72-2-1121 SCORPIO CR TIBIAL TRIAL, SIZE 11, 21 MM T72-2-1124 SCORPIO CR TIBIAL TRIAL, SIZE 11, 24 MM All lots. 
Recalling Firm/
Manufacturer		 Stryker Howmedica Osteonics Corp.
325 Corporate Drive
Mahwah NJ 07430
For Additional Information Contact Richard Wolyn
201-972-2100
Manufacturer Reason
for Recall		 Stryker Orthopaedics became aware that there is the potential for the Scorpio T72 tibial Insert Trials to be oversized by a maximum of .024" (0.6mm).
FDA Determined
Cause 2		 Other
Action Stryker Howmedica Osteonics Corp.sent Urgent Product Correction letters Correction letters dated July 23, 2010, via Federal Express to all affected customers. were sent to all Stryker Branches on July 23, 2010 via Federal Express. Asia Pacific, Canada, Europe, Middle East, Africa, Japan and Latin America sites were sent letters on July 26, 2010 by Federal Express. The letters identified the product, the problem, and the action to be taken by the customer. Customers were instructed to complete and return the attached Product Correction Acknowledgement Form by fax as soon as possible to 201-831-6069. For any questions customers were to call 201-972-2100 or 201-831-5028.
Quantity in Commerce 159,095 units, all types.
Distribution Worldwide Distribution - USA including OH, TX, MS, and CO and the countries of Australia, Hong Kong, Taiwan, India, Korea, Japan, Chile, Brazil, Columbia, Venezuela, , Panama, Santo Domingo, Mexico, Argentina, Costa Rica, Guatemala, Peru,Sweden, Germany, Netherlands, France, Spain, Italy, Romania, South Africa, United Kingdom. and Canada.
Total Product Life Cycle TPLC Device Report
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
-
-